✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Your cart is empty
GLP-1 / Glucagon Dual Agonist
Also known as IBI362 / LY3305677
Mazdutide is a synthetic peptide studied in research as a dual agonist of the glucagon-like peptide-1 (GLP-1) and glucagon receptors.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Mazdutide is a synthetic peptide studied in research as a dual agonist of the glucagon-like peptide-1 (GLP-1) and glucagon receptors.
Experimental models examine its combined incretin and glucagon signaling within controlled metabolic frameworks.
Third-party tested for purity, ID, quantity.
Mazdutide is a GLP-1/glucagon receptor dual agonist based on the oxyntomodulin scaffold, characterized in research for combined activation of two metabolic-regulatory receptors. Investigations have examined effects on glycemic control and body-weight endpoints in clinical research populations.
Studies evaluate the dual-agonist pharmacology and metabolic outcomes under structured conditions.
Mazdutide emerged from research into multi-receptor incretin agonists designed to combine the metabolic effects of GLP-1 and glucagon signaling.
Clinical trials have since characterized its efficacy and pharmacology in obesity and type 2 diabetes research.
Research into mazdutide focuses on GLP-1/glucagon dual-receptor signaling and metabolic regulation. Frameworks evaluate glycemic control, energy expenditure, and body-weight endpoints under controlled clinical and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of mazdutide. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial
PubMedSeven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials
PubMedRelated
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$70.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$50.00
Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$60.00
GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$90.00
